Novozymes has signed a definitive agreement to acquire Natural Industries Inc., based in Houston, Texas. Natural Industries Inc. is a bioagricultural player with annual revenues of $5 million. Natural Industries Inc. and Novozymes have agreed not to disclose the financial terms of the agreement, and the acquisition does not impact Novozymes’ financial guidance for 2012.
“I am excited to have the people and technologies of Natural Industries Inc. join our growing BioAg business,” says Thomas Videbæk, Executive Vice President of Novozymes and head of BioBusiness. “Natural Industries Inc. expands Novozymes’ position in the important biocontrol segment and improves our capabilities to grow our business in key U.S. markets on high-value crops like fruits and vegetables.”
“Founded in 1992 and with 24 talented employees, Natural Industries Inc. brings a wealth of knowledge in the biocontrol area,” Videbæk says. “The company has a proven portfolio of products, new pipeline opportunities and good market coverage for high-value crops in key regions of the U.S. The acquisition is a good example of how we can grow and utilize our platform and leading position in this area, as well as accelerate innovation.
“Novozymes has long-term ambitions to be a key player in this market. With our platform today, our expertise within bioinnovation and research and development, we expect to continue to play a leading role in growing the bioagriculture market.”